The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder.
about
Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic reviewCanadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersTargeting memory processes with drugs to prevent or cure PTSDPTSD: from neurobiology to pharmacological treatmentsPharmacotherapy of PTSD: premises, principles, and prioritiesGAD65 haplodeficiency conveys resilience in animal models of stress-induced psychopathologyPathophysiological mechanisms underlying increased anxiety after soman exposure: reduced GABAergic inhibition in the basolateral amygdala.Post-traumatic stress disorder: emerging concepts of pharmacotherapy.PSYCHOTHERAPY VERSUS PHARMACOTHERAPY FOR POSTTRAUMATIC STRESS DISORDER: SYSTEMIC REVIEW AND META-ANALYSES TO DETERMINE FIRST-LINE TREATMENTS.Pharmacotherapy in post-traumatic stress disorder: evidence from randomized controlled trialsPost-traumatic stress disorder: an evaluation of existing pharmacotherapies and new strategies.Treatment of Post-Traumatic Stress Disorder Nightmares at a Veterans Affairs Medical Center.Psychopharmacological issues in the treatment of TBI and PTSD.Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD).Modulation of ion channels in clinical psychopharmacology: adults and younger people.Cancer and post-traumatic stress disorder: diagnosis, pathogenesis and treatment considerations.A pharmacotherapeutic approach to the management of chronic posttraumatic stress disorder.Anticonvulsants to treat post-traumatic stress disorder.Anticonvulsant Medication Use in Veterans With Posttraumatic Stress Disorder.Pharmacotherapy of post-traumatic stress disorder: going beyond the guidelines.The sleep effects of tiagabine on the first night of treatment predict post-traumatic stress disorder response at three weeks.A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD.A perspective on the contribution of animal models to the pharmacological treatment of posttraumatic stress disorder.Posttraumatic Stress Disorder: An Integrated Overview of the Neurobiological Rationale for Pharmacology
P2860
Q24657469-F2B4AA57-D1BC-46FB-9561-7EF899ED0E08Q27009995-2AE4003E-6303-4DB0-8004-F54ED4D9FC9DQ27016155-5D4893F1-67CA-428C-A5C4-DFF8DE062C19Q28070159-B3657900-48AC-4033-A2DA-D633CE4B9345Q30479154-8D029F07-283C-4F21-A0B5-E196559404C2Q34013738-55305646-76FA-4F64-B950-708B71B1AC81Q34243946-9E9C1FD5-30ED-4F2C-B786-794FCA6B4E6CQ34981801-0CEEBA96-8BCB-4D51-9457-DD50108F4402Q36002473-6C7BA9F3-BE40-4844-B7CE-1F69E777C321Q36777691-B94639B5-8FFB-4E2C-AA60-7FE920A200F5Q36909270-3D9BE04D-60C4-4968-A005-C6BF01D6CBB4Q37532398-BCAF6541-3755-4C56-9752-30713EAF6517Q37625940-6FFB51B5-2703-46E3-B95B-5D30821422CDQ37907415-5E0D70AF-2CB4-4F0A-86F7-4AA1E0C2B4CCQ37960095-E02F4FA1-D888-4A60-86F4-E9B210C35C97Q37995764-0ABB1647-C878-4BA4-884F-35264D701CF7Q38006441-56D29BBF-FD3F-4268-A12A-5DECE19A7910Q38240674-928E2480-35F8-4770-8722-38F0D5FB29E1Q38750774-A640EF07-307C-48D3-A701-E141A0C94C20Q42362606-43934E2B-93A6-4204-BD2E-15B35172C0A3Q43715889-9EF54BC3-149A-4C78-AC73-5CF1167CAC1BQ48874272-6F6C8FF0-07B6-4930-8458-345B5349D690Q53141044-995EC482-4A23-4D47-8DED-B8BC036DE2A2Q58213889-B3C96725-AFB6-42DE-A9F6-1DA5276BFE4F
P2860
The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
The efficacy and tolerability ...... ost-traumatic stress disorder.
@en
The efficacy and tolerability ...... ost-traumatic stress disorder.
@nl
type
label
The efficacy and tolerability ...... ost-traumatic stress disorder.
@en
The efficacy and tolerability ...... ost-traumatic stress disorder.
@nl
prefLabel
The efficacy and tolerability ...... ost-traumatic stress disorder.
@en
The efficacy and tolerability ...... ost-traumatic stress disorder.
@nl
P2093
P1476
The efficacy and tolerability ...... ost-traumatic stress disorder.
@en
P2093
Jonathan R T Davidson
Kathleen Brady
Mark H Pollack
Murray B Stein
Thomas A Mellman
P356
10.1097/JCP.0B013E31802E5115
P407
P577
2007-02-01T00:00:00Z